Best in Biotech 25 Jan 2024
Eight mental health biotech companies trying to make a difference to people’s lives
Take a closer look at eight mental health companies developing therapies that could make a different to people with mental illnesses.
- Latest Posts
In Depth 24 Jan 2024
A new chapter in cell therapy: engineered B cells reach the clinic for the first time
Cell therapy has drastically improved the scope of treatment for a number of diseases in the last few years. Now, engineered B cells are the latest approach in the field of cell therapy, having recently made it into clinical trials. But what exactly are B cells and how can they be engineered to treat diseases? […]
Best in Biotech 23 Jan 2024
19 French biotechs you should know about
France is at the forefront of innovative biotech and Paris has become a vibrant startup ecosystem. Here are 19 top French biotech companies!
Best in Biotech 22 Jan 2024
Eight newly approved drugs that could become blockbusters in 2024
The much-awaited Drugs to Watch list by Clarivate is out. Let’s do a deep dive into the therapies that made the cut in 2024.
In Depth 19 Jan 2024
Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases?
Check out our latest article as we explore some of the latest research around using CRISPR technology to treat neurodegenerative diseases.
Podcast 19 Jan 2024
Epigenetic editing – the power of CRISPR without cutting DNA
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]
ADVERTISEMENT
ADVERTISEMENT
In Depth 18 Jan 2024
GLP-1 agonists: what’s the hype about?
GLP-1 agonists have been on the radar for a while to treat diabetes and obesity. And of late, there has been renewed interest in these drugs.
News and Trends 18 Jan 2024
2024 J.P. Morgan Healthcare Conference: key takeaways from the largest biotech gathering of the year
Here are some of the key takeaways from the JPM Healthcare Conference that lay the groundwork for what we can expect in 2024.
In Depth 17 Jan 2024
Bladder cancer treatment: where are we standing?
Bladder cancer is the 10th most common cancer. Delve into the most promising strides in bladder cancer treatment.
Best in Biotech 16 Jan 2024
Five biotech companies taking Florida by storm
Check out five of the top Florida companies taking the state’s biotech industry by storm with their innovative technologies.
Mastering biologics tech transfer: key success factors
Unlock the secrets of efficient tech transfers for biologics, and explore critical stages and success factors.
In Depth 15 Jan 2024
The future of diabetes treatment: Is a cure possible?
Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we?
ADVERTISEMENT
